Immuron Limited · ASX:IMC

Immuron — Shareholder Meeting (November 2014)

22 slides from Immuron's shareholder meeting presentation, Nov 13, 2014

  1. Slide 1: AGM Nov 2014

    For personal use only AGM Nov 2014 IMMURON

  2. Slide 2: Forward-looking Statement

    Forward-looking Statement For personal use only Certain statements made in this presentation are forward-looking statements and are based on Immuron’s current expectations, estimates and projections. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “guida

  3. Slide 3: Summary upfront

    Overview, TRAVELAN® NASH/ASH PIPELINE LOOKING FORWARD Achievements For personal use only Summary upfront NASH: Trials are “go ready” An increasingly alluring potential upside Travelan: Revenues growing and positioned to grow further Pipeline: Progressing Cap Str: Robust Financials: Debt free, cash i

  4. Slide 4: Achievements 2014

    Overview, TRAVELAN® NASH/ASH PIPELINE LOOKING FORWARD Achievements For personal use only Achievements 2014 Improve: 1. Capital Raise: ~$9.66M Financials and 2. Paladin Debt Extinguished Capital Structure 3. Mop Up Unmarketable Parcels 4. Improve Hadassah royalty rates Progress 5. Increase Travelan S

  5. Slide 5: Robust Capital Structure

    Overview, TRAVELAN® NASH/ASH PIPELINE LOOKING FORWARD Achievements Robust Capital Structure For personal use only Nov 2013 Nov/Dec 2014 Cash • <$1M cash at 30 Dec 13 $6M cash at 30 June 14 • CAD1.5M Paladin Debt Debt Free Debt owing Share • 1,800 shareholders on ~1,200 SH following Mop Up Register r

  6. Slide 6: Travelan Achievements

    For personal use only 2. TRAVELAN® ACHIEVEMENTS

  7. Slide 7: Travelan: Increasing Australian Presence

    Overview, TRAVELAN NASH PIPELINE LOOKING FORWARD Achievements Travelan® For personal use only Increasing Australian Presence Sales through pharmacies Sales & marketing to doctors Online 7 Immuron AGM Presentation Nov 2015

  8. Slide 8: Travelan Pharmacy: Increasing Sales

    Overview, TRAVELAN NASH PIPELINE LOOKING FORWARD Achievements Travelan® For personal use only Pharmacy Sales through pharmacies MARKETING PROGRAM 1. Co-promotion 2. CPD Program 3. Guild Conference 8 Increasing Sales Immuron AGM Presentation Nov 2015

  9. Slide 9: Travelan Doctors: Sales & marketing to doctors

    Overview, TRAVELAN NASH PIPELINE LOOKING FORWARD Achievements Travelan® For personal use only Doctors Sales & marketing to doctors 1. Specialized sales rep 2. Target franchised travel clinics 3. Engage with specialized wholesaler: Equip 9 4. Engage with KOLs Immuron AGM 5. Attend Travel Medicine Pre

  10. Slide 10: Travelan Online

    Overview, TRAVELAN NASH PIPELINE LOOKING FORWARD Achievements Travelan® For personal use only Online 1. Upgrade: www.travelan.com.au 2. Online advertising 3. Facebook summer campaign Online 10 Immuron AGM Presentation Nov 2015

  11. Slide 11: Successful Canadian Launch

    Overview, TRAVELAN NASH PIPELINE LOOKING FORWARD Achievements Travelan® For personal use only Succesful Canadian Launch Exceeding Expectations 11 Immuron AGM Presentation Nov 2015

  12. Slide 12: Travelan international status by country

    Overview, TRAVELAN NASH PIPELINE LOOKING FORWARD Achievements Travelan® For personal use only Status in Nov 2013 Progress in 2014 Country Discussions Term Sheet Licensed Regulatory In Market Canada South Korea Other Asian Countries US (partnered) No regulatory process United States (direct) India Ch

  13. Slide 13: NASH/ASH (Inflamed Fatty Liver)

    For personal use only 3. NASH/ASH (INFLAMED FATTY LIVER)

  14. Slide 14: NASH: What we have done in 2014

    Overview, TRAVELAN NASH/ASH NASH/ASH PIPELINE LOOKING FORWARD Achievements NASH For personal use only What we have done in 2014 Appoint internal team Update 1. Protocol February 2014 2. Investigational Brochure Capital Raise Formulation and Select and Engage with: manufacture of 1. Monitors clinical

  15. Slide 15: Central Co-ordination & Analysis

    Overview, TRAVELAN NASH/ASH PIPELINE LOOKING FORWARD Achievements Central Co-ordination & Analysis For personal use only MRI VirtualScopics Medical Monitor Rochester NY Prof Y Ilan Hadassah Medical Center Israel Liver biopsy/M’biome Duke CRI Central Pharmacy US Durham NC The Coghlan Group Bastrop, T

  16. Slide 16: Sites - Australia

    Sites - Australia For personal use only Princess Alexandra Hospital, Brisbane, QLD Westmead Hospital, Sydney, NSW Nepean Hospital, Sydney, NSW Box Hill Hospital Melbourne, VIC Royal Melbourne Alfred Hospital Hospital, VIC Melbourne, VIC

  17. Slide 17: Sites – United States

    Sites – United States For personal use only Swedish MC Seattle, WA UVA, Charlottesville VA VCU, Richmond VA Bon Secours, Richmond/NN, VA Cleveland Clinic, OH U.Colorado, Denver, CO Duke Liver Center, Kansas City GE&H, MO Durham NC U Florida, Gainesville, FL Baylor St Luke’s Houston, TX 17 Immuron In

  18. Slide 18: Pipeline

    For personal use only 4. PIPELINE

  19. Slide 19: C. Difficile: Progressing to the clinic

    Overview, TRAVELAN® NASH/ASH PIPELINE LOOKING FORWARD Achievements For personal use only C. Difficile Progressing to the clinic A promising program Continuing Collaboration with Monash Potential to leverage into other indications 19 Immuron AGM Presentation Nov 2015

  20. Slide 20: Looking Forward

    For personal use only 5. LOOKING FORWARD

  21. Slide 21: Looking Forward 2015

    Overview, TRAVELAN® NASH/ASH PIPELINE LOOKING FORWARD Achievements For personal use only Looking Forward 2015 Travelan 1. Continue to increase Australian Travelan revenue 2. Increase Canadian Travelan revenue 3. Launch in the US 4. Continue to progress elsewhere overseas Another Product 4. Launch an

  22. Slide 22: Thank You

    For personal use only THANK YOU Chief Executive Officer Amos Meltzer amos@immuron.com

Immuron — Shareholder Meeting (November 2014) on 6ix